13:28 IST
NSE
Adverse Business Impact
OneSource Specialty Pharma Adverse Business Impact
OneSource Specialty Pharma decided not to pursue its proposed merger scheme with SteriScience facilities. The company plans to revisit the transaction following FY28 guidance delivery.